Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in COLL — Collegium Pharmaceutical, Inc

CIK 72971 SAN FRANCISCO, CA
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,753,178
+$891,269 QoQ
Shares Held
103,679
+19.8% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. COLL ranks #21 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,809,278 $130,014,715
2 HLN
Haleon plc
 4,924,330 $45,943,997
3 NBIX
Neurocrine Biosciences Inc
 253,026 $42,644,999
4 UTHR
UNITED THERAPEUTICS Corp
 74,303 $40,259,592
5 ELAN
Elanco Animal Health Inc
 976,361 $24,028,242
6 HIMS
Hims & Hers Health, Inc.
 559,389 $19,394,014
7 VTRS
Viatris Inc
 1,175,495 $18,666,859
8 TAK
Takeda Pharmaceutical Co Ltd
 1,150,820 $18,447,643

All Filings in COLL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,753,178 103,679
2026-03-31 $2,861,909 86,541
2025-12-31 $2,666,323 57,588
2025-09-30 $782,585 22,366
2025-06-30 $522,323 17,664
2025-03-31 $478,823 16,041
2024-12-31 $590,733 20,619
2024-09-30 $1,182,615 30,606
2024-06-30 $532,362 16,533
2024-03-31 $711,686 18,333
2023-12-31 $338,240 10,989
2023-09-30 $251,883 11,270
2023-06-30 $434,913 20,238
2023-03-31 $363,542 15,154
2022-12-31 $79,784 3,439
2022-09-30 $72,378 4,518
2022-06-30 $84,187 4,751
2022-03-31 $1,473,962 72,395
2021-12-31 $1,720,258 92,091
2021-09-30 $2,625,537 133,006
2021-06-30 $2,995,139 126,698
2021-03-31 $3,379,571 142,598
2020-12-31 $2,203,558 110,013
2020-09-30 $2,140,148 102,793
2020-06-30 $1,560,824 89,190
2020-03-31 $1,240,474 75,963